HEADER GENE REGULATION 13-SEP-23 8QJR TITLE BRG1 BROMODOMAIN IN COMPLEX WITH VBC VIA COMPOUND 17 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ELONGIN-B; COMPND 3 CHAIN: A, D; COMPND 4 SYNONYM: ELOB,ELONGIN 18 KDA SUBUNIT,RNA POLYMERASE II TRANSCRIPTION COMPND 5 FACTOR SIII SUBUNIT B,SIII P18,TRANSCRIPTION ELONGATION FACTOR B COMPND 6 POLYPEPTIDE 2; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: ELONGIN-C; COMPND 10 CHAIN: B, E; COMPND 11 SYNONYM: ELOC,ELONGIN 15 KDA SUBUNIT,RNA POLYMERASE II TRANSCRIPTION COMPND 12 FACTOR SIII SUBUNIT C,SIII P15,TRANSCRIPTION ELONGATION FACTOR B COMPND 13 POLYPEPTIDE 1; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR; COMPND 17 CHAIN: C, F; COMPND 18 SYNONYM: PROTEIN G7,PVHL; COMPND 19 ENGINEERED: YES; COMPND 20 MOL_ID: 4; COMPND 21 MOLECULE: TRANSCRIPTION ACTIVATOR BRG1; COMPND 22 CHAIN: G, H; COMPND 23 FRAGMENT: UNP RESIDUES 1418-1536; COMPND 24 SYNONYM: ATP-DEPENDENT HELICASE SMARCA4,BRG1-ASSOCIATED FACTOR 190A, COMPND 25 BAF190A,MITOTIC GROWTH AND TRANSCRIPTION ACTIVATOR,PROTEIN BRG-1, COMPND 26 PROTEIN BRAHMA HOMOLOG 1,SNF2-BETA,SWI/SNF-RELATED MATRIX-ASSOCIATED COMPND 27 ACTIN-DEPENDENT REGULATOR OF CHROMATIN SUBFAMILY A MEMBER 4; COMPND 28 EC: 3.6.4.-; COMPND 29 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ELOB, TCEB2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: ELOC, TCEB1; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 GENE: VHL; SOURCE 20 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 22 MOL_ID: 4; SOURCE 23 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 24 ORGANISM_COMMON: HUMAN; SOURCE 25 ORGANISM_TAXID: 9606; SOURCE 26 GENE: SMARCA4, BAF190A, BRG1, SNF2B, SNF2L4; SOURCE 27 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 28 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BRG1, BROMODOMAIN, VHL, ELONGIN, VBC, E3 LIGASE, VON HIPPEL-LINDAU, KEYWDS 2 UBIQUITINASE, GENE REGULATION EXPDTA X-RAY DIFFRACTION AUTHOR P.S.KERRY,A.J.HOLE,J.I.PEREZ-DORADO REVDAT 2 07-FEB-24 8QJR 1 JRNL REVDAT 1 17-JAN-24 8QJR 0 JRNL AUTH M.BERLIN,J.CANTLEY,M.BOOKBINDER,E.BORTOLON,F.BROCCATELLI, JRNL AUTH 2 G.CADELINA,E.W.CHAN,H.CHEN,X.CHEN,Y.CHENG,T.K.CHEUNG, JRNL AUTH 3 K.DAVENPORT,D.DINICOLA,D.GORDON,B.D.HAMMAN,A.HARBIN, JRNL AUTH 4 R.HASKELL,M.HE,A.J.HOLE,T.JANUARIO,P.S.KERRY,S.G.KOENIG, JRNL AUTH 5 L.LI,M.MERCHANT,I.PEREZ-DORADO,J.PIZZANO,C.QUINN,C.M.ROSE, JRNL AUTH 6 E.ROUSSEAU,L.SOTO,L.R.STABEN,H.SUN,Q.TIAN,J.WANG,W.WANG, JRNL AUTH 7 C.S.YE,X.YE,P.ZHANG,Y.ZHOU,R.YAUCH,P.S.DRAGOVICH JRNL TITL PROTACS TARGETING BRM (SMARCA2) AFFORD SELECTIVE IN VIVO JRNL TITL 2 DEGRADATION OVER BRG1 (SMARCA4) AND ARE ACTIVE IN BRG1 JRNL TITL 3 MUTANT XENOGRAFT TUMOR MODELS. JRNL REF J.MED.CHEM. V. 67 1262 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 38180485 JRNL DOI 10.1021/ACS.JMEDCHEM.3C01781 REMARK 2 REMARK 2 RESOLUTION. 3.17 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 (8-JUN-2022) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.17 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 80.64 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 20137 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.263 REMARK 3 R VALUE (WORKING SET) : 0.262 REMARK 3 FREE R VALUE : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 966 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 3.17 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.19 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3189 REMARK 3 BIN FREE R VALUE : 0.3740 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 16 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7290 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 196 REMARK 3 SOLVENT ATOMS : 57 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 67.49 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.43450 REMARK 3 B22 (A**2) : 2.75390 REMARK 3 B33 (A**2) : -5.18840 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -12.83280 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.510 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.523 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.865 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.862 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 7656 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 10370 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2769 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 1262 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 7656 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 976 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6033 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 0.75 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.38 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.17 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 9 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|1 - A|103 } REMARK 3 ORIGIN FOR THE GROUP (A): 69.7562 -7.9617 27.8140 REMARK 3 T TENSOR REMARK 3 T11: -0.0032 T22: -0.0546 REMARK 3 T33: -0.1941 T12: 0.0219 REMARK 3 T13: 0.0699 T23: 0.0657 REMARK 3 L TENSOR REMARK 3 L11: 10.4352 L22: 1.8365 REMARK 3 L33: 2.2724 L12: 1.2377 REMARK 3 L13: -1.0424 L23: -0.789 REMARK 3 S TENSOR REMARK 3 S11: -0.0968 S12: -0.2379 S13: 0.1358 REMARK 3 S21: -0.2379 S22: -0.1117 S23: 0.6381 REMARK 3 S31: 0.1358 S32: 0.6381 S33: 0.2085 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|16 - B|112 } REMARK 3 ORIGIN FOR THE GROUP (A): 53.7133 -1.1242 22.9995 REMARK 3 T TENSOR REMARK 3 T11: -0.1448 T22: -0.1928 REMARK 3 T33: -0.0659 T12: 0.0477 REMARK 3 T13: -0.0591 T23: -0.0085 REMARK 3 L TENSOR REMARK 3 L11: 7.7995 L22: 5.8167 REMARK 3 L33: 3.0072 L12: 1.7538 REMARK 3 L13: -2.1357 L23: -2.0029 REMARK 3 S TENSOR REMARK 3 S11: -0.1392 S12: -0.35 S13: -0.3125 REMARK 3 S21: -0.35 S22: -0.0962 S23: 0.1988 REMARK 3 S31: -0.3125 S32: 0.1988 S33: 0.2355 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: { C|61 - C|213 } REMARK 3 ORIGIN FOR THE GROUP (A): 33.3895 -17.6788 13.2558 REMARK 3 T TENSOR REMARK 3 T11: 0.0051 T22: -0.1883 REMARK 3 T33: -0.0481 T12: -0.0249 REMARK 3 T13: 0.0546 T23: 0.0248 REMARK 3 L TENSOR REMARK 3 L11: 1.6744 L22: 1.9148 REMARK 3 L33: 1.5016 L12: -0.3813 REMARK 3 L13: 0.1471 L23: -0.2635 REMARK 3 S TENSOR REMARK 3 S11: -0.017 S12: -0.2705 S13: -0.0937 REMARK 3 S21: -0.2705 S22: 0.022 S23: -0.09 REMARK 3 S31: -0.0937 S32: -0.09 S33: -0.005 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: { D|1 - D|103 } REMARK 3 ORIGIN FOR THE GROUP (A): 32.5078 -3.3705 -38.4375 REMARK 3 T TENSOR REMARK 3 T11: -0.109 T22: 0.0829 REMARK 3 T33: -0.1643 T12: -0.0359 REMARK 3 T13: -0.0603 T23: -0.0861 REMARK 3 L TENSOR REMARK 3 L11: 4.788 L22: 1.2434 REMARK 3 L33: 5.9226 L12: 0.229 REMARK 3 L13: -3.4095 L23: 0.0923 REMARK 3 S TENSOR REMARK 3 S11: -0.0621 S12: -0.4941 S13: -0.0441 REMARK 3 S21: -0.4941 S22: 0.0524 S23: -0.724 REMARK 3 S31: -0.0441 S32: -0.724 S33: 0.0098 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 SELECTION: { E|16 - E|112 } REMARK 3 ORIGIN FOR THE GROUP (A): 28.6051 -9.9265 -22.0496 REMARK 3 T TENSOR REMARK 3 T11: 0.0169 T22: -0.1908 REMARK 3 T33: -0.165 T12: -0.0708 REMARK 3 T13: 0.0963 T23: 0.0091 REMARK 3 L TENSOR REMARK 3 L11: 6.2253 L22: 7.8292 REMARK 3 L33: 4.9265 L12: -3.046 REMARK 3 L13: -3.2901 L23: 2.7112 REMARK 3 S TENSOR REMARK 3 S11: -0.2371 S12: 0.0305 S13: 0.6195 REMARK 3 S21: 0.0305 S22: -0.1908 S23: -0.3927 REMARK 3 S31: 0.6195 S32: -0.3927 S33: 0.4279 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 SELECTION: { F|60 - F|213 } REMARK 3 ORIGIN FOR THE GROUP (A): 26.1312 6.8697 0.3594 REMARK 3 T TENSOR REMARK 3 T11: -0.073 T22: -0.138 REMARK 3 T33: -0.101 T12: 0.0118 REMARK 3 T13: 0.0771 T23: 0.0166 REMARK 3 L TENSOR REMARK 3 L11: 1.1925 L22: 3.1982 REMARK 3 L33: 3.0861 L12: -0.1074 REMARK 3 L13: 0.0706 L23: 0.6743 REMARK 3 S TENSOR REMARK 3 S11: 0.1129 S12: 0.2911 S13: 0.0278 REMARK 3 S21: 0.2911 S22: -0.0878 S23: -0.3834 REMARK 3 S31: 0.0278 S32: -0.3834 S33: -0.0252 REMARK 3 REMARK 3 TLS GROUP : 7 REMARK 3 SELECTION: { G|1457 - G|1566 } REMARK 3 ORIGIN FOR THE GROUP (A): 13.5842 -56.0225 5.0354 REMARK 3 T TENSOR REMARK 3 T11: -0.0084 T22: -0.3012 REMARK 3 T33: -0.0771 T12: 0.109 REMARK 3 T13: 0.0458 T23: -0.0763 REMARK 3 L TENSOR REMARK 3 L11: 3.2626 L22: 5.086 REMARK 3 L33: 6.5887 L12: 0.0601 REMARK 3 L13: -0.2817 L23: -1.1496 REMARK 3 S TENSOR REMARK 3 S11: -0.2188 S12: 0.1578 S13: -0.2232 REMARK 3 S21: 0.1578 S22: 0.1865 S23: -0.0102 REMARK 3 S31: -0.2232 S32: -0.0102 S33: 0.0324 REMARK 3 REMARK 3 TLS GROUP : 8 REMARK 3 SELECTION: { H|1457 - H|1559 } REMARK 3 ORIGIN FOR THE GROUP (A): 24.0726 44.4506 24.2194 REMARK 3 T TENSOR REMARK 3 T11: 0.0983 T22: -0.1523 REMARK 3 T33: 0.0331 T12: -0.1356 REMARK 3 T13: 0.0036 T23: 0.2775 REMARK 3 L TENSOR REMARK 3 L11: 11.1133 L22: 7.6354 REMARK 3 L33: 6.2088 L12: 2.5306 REMARK 3 L13: -0.2368 L23: -1.6855 REMARK 3 S TENSOR REMARK 3 S11: -0.2237 S12: -0.3259 S13: 0.2342 REMARK 3 S21: -0.3259 S22: 0.9146 S23: -0.84 REMARK 3 S31: 0.2342 S32: -0.84 S33: -0.6909 REMARK 3 REMARK 3 TLS GROUP : 9 REMARK 3 SELECTION: { C|305 - C|305 F|303 - F|303 } REMARK 3 ORIGIN FOR THE GROUP (A): 25.6193 -5.4095 9.1501 REMARK 3 T TENSOR REMARK 3 T11: -0.0408 T22: -0.3534 REMARK 3 T33: -0.0857 T12: -0.0194 REMARK 3 T13: 0.1029 T23: 0.0172 REMARK 3 L TENSOR REMARK 3 L11: -0.1238 L22: 0.8553 REMARK 3 L33: 0.1238 L12: -0.0857 REMARK 3 L13: 0.1999 L23: 0.0432 REMARK 3 S TENSOR REMARK 3 S11: -0.018 S12: 0.0176 S13: 0.0047 REMARK 3 S21: 0.0176 S22: 0.0824 S23: -0.0621 REMARK 3 S31: 0.0047 S32: -0.0621 S33: -0.0645 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8QJR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-SEP-23. REMARK 100 THE DEPOSITION ID IS D_1292133247. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-MAR-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20137 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.170 REMARK 200 RESOLUTION RANGE LOW (A) : 80.640 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.15000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.17 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.39 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.57800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 27 MM HEPES PH 6.8, 73 MM HEPES PH REMARK 280 8.6, 1.0 M NAI, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 83.84000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.02200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 83.84000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 44.02200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 104 REMARK 465 GLY B 48 REMARK 465 PRO B 49 REMARK 465 GLY B 50 REMARK 465 GLN B 51 REMARK 465 PHE B 52 REMARK 465 ALA B 53 REMARK 465 GLU B 54 REMARK 465 ASN B 55 REMARK 465 GLU B 56 REMARK 465 THR B 57 REMARK 465 GLY C 52 REMARK 465 SER C 53 REMARK 465 MET C 54 REMARK 465 GLU C 55 REMARK 465 ALA C 56 REMARK 465 GLY C 57 REMARK 465 ARG C 58 REMARK 465 PRO C 59 REMARK 465 ARG C 60 REMARK 465 LYS D 104 REMARK 465 SER E 47 REMARK 465 GLY E 48 REMARK 465 PRO E 49 REMARK 465 GLY E 50 REMARK 465 GLN E 51 REMARK 465 PHE E 52 REMARK 465 ALA E 53 REMARK 465 GLU E 54 REMARK 465 ASN E 55 REMARK 465 GLU E 56 REMARK 465 GLY F 52 REMARK 465 SER F 53 REMARK 465 MET F 54 REMARK 465 GLU F 55 REMARK 465 ALA F 56 REMARK 465 GLY F 57 REMARK 465 ARG F 58 REMARK 465 PRO F 59 REMARK 465 SER G 1449 REMARK 465 MET G 1450 REMARK 465 LEU G 1451 REMARK 465 SER G 1452 REMARK 465 PRO G 1453 REMARK 465 ASN G 1454 REMARK 465 PRO G 1455 REMARK 465 PRO G 1456 REMARK 465 GLU G 1567 REMARK 465 ASP G 1568 REMARK 465 ASP G 1569 REMARK 465 SER H 1449 REMARK 465 MET H 1450 REMARK 465 LEU H 1451 REMARK 465 SER H 1452 REMARK 465 PRO H 1453 REMARK 465 ASN H 1454 REMARK 465 PRO H 1455 REMARK 465 PRO H 1456 REMARK 465 SER H 1477 REMARK 465 GLY H 1478 REMARK 465 VAL H 1560 REMARK 465 ARG H 1561 REMARK 465 GLN H 1562 REMARK 465 LYS H 1563 REMARK 465 ILE H 1564 REMARK 465 GLU H 1565 REMARK 465 LYS H 1566 REMARK 465 GLU H 1567 REMARK 465 ASP H 1568 REMARK 465 ASP H 1569 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 CA GLU G 1483 NZ LYS H 1473 1545 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 10 -130.47 59.39 REMARK 500 ALA A 67 72.21 -113.84 REMARK 500 ASP A 82 -140.46 64.12 REMARK 500 ASN B 85 71.41 -107.98 REMARK 500 ARG C 69 8.54 59.43 REMARK 500 PRO C 103 100.82 -59.48 REMARK 500 SER C 111 -161.18 -128.21 REMARK 500 GLN C 132 -23.39 76.66 REMARK 500 SER C 139 -161.02 -101.48 REMARK 500 HIS D 10 -130.41 59.20 REMARK 500 ALA D 67 72.18 -113.95 REMARK 500 ASP D 82 -77.01 65.33 REMARK 500 ASP D 83 -42.87 -138.51 REMARK 500 ASN E 85 71.06 -107.75 REMARK 500 ARG F 69 8.40 59.58 REMARK 500 PRO F 103 100.78 -59.52 REMARK 500 SER F 111 -161.14 -128.22 REMARK 500 GLN F 132 -23.23 76.53 REMARK 500 SER F 139 -161.06 -101.53 REMARK 500 REMARK 500 REMARK: NULL DBREF 8QJR A 1 104 UNP Q15370 ELOB_HUMAN 1 104 DBREF 8QJR B 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 8QJR C 54 213 UNP P40337 VHL_HUMAN 54 213 DBREF 8QJR D 1 104 UNP Q15370 ELOB_HUMAN 1 104 DBREF 8QJR E 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 8QJR F 54 213 UNP P40337 VHL_HUMAN 54 213 DBREF 8QJR G 1451 1569 UNP P51532 SMCA4_HUMAN 1418 1536 DBREF 8QJR H 1451 1569 UNP P51532 SMCA4_HUMAN 1418 1536 SEQADV 8QJR MET B 16 UNP Q15369 INITIATING METHIONINE SEQADV 8QJR GLY C 52 UNP P40337 EXPRESSION TAG SEQADV 8QJR SER C 53 UNP P40337 EXPRESSION TAG SEQADV 8QJR MET E 16 UNP Q15369 INITIATING METHIONINE SEQADV 8QJR GLY F 52 UNP P40337 EXPRESSION TAG SEQADV 8QJR SER F 53 UNP P40337 EXPRESSION TAG SEQADV 8QJR SER G 1449 UNP P51532 EXPRESSION TAG SEQADV 8QJR MET G 1450 UNP P51532 EXPRESSION TAG SEQADV 8QJR SER H 1449 UNP P51532 EXPRESSION TAG SEQADV 8QJR MET H 1450 UNP P51532 EXPRESSION TAG SEQRES 1 A 104 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 A 104 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 A 104 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 A 104 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 A 104 ASP GLY LYS THR LEU GLY GLU CYS GLY PHE THR SER GLN SEQRES 6 A 104 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 A 104 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CYS ILE GLU SEQRES 8 A 104 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 1 B 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 B 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 B 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 B 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 B 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 B 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 B 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 B 97 ALA ASN PHE LEU ASP CYS SEQRES 1 C 162 GLY SER MET GLU ALA GLY ARG PRO ARG PRO VAL LEU ARG SEQRES 2 C 162 SER VAL ASN SER ARG GLU PRO SER GLN VAL ILE PHE CYS SEQRES 3 C 162 ASN ARG SER PRO ARG VAL VAL LEU PRO VAL TRP LEU ASN SEQRES 4 C 162 PHE ASP GLY GLU PRO GLN PRO TYR PRO THR LEU PRO PRO SEQRES 5 C 162 GLY THR GLY ARG ARG ILE HIS SER TYR ARG GLY HIS LEU SEQRES 6 C 162 TRP LEU PHE ARG ASP ALA GLY THR HIS ASP GLY LEU LEU SEQRES 7 C 162 VAL ASN GLN THR GLU LEU PHE VAL PRO SER LEU ASN VAL SEQRES 8 C 162 ASP GLY GLN PRO ILE PHE ALA ASN ILE THR LEU PRO VAL SEQRES 9 C 162 TYR THR LEU LYS GLU ARG CYS LEU GLN VAL VAL ARG SER SEQRES 10 C 162 LEU VAL LYS PRO GLU ASN TYR ARG ARG LEU ASP ILE VAL SEQRES 11 C 162 ARG SER LEU TYR GLU ASP LEU GLU ASP HIS PRO ASN VAL SEQRES 12 C 162 GLN LYS ASP LEU GLU ARG LEU THR GLN GLU ARG ILE ALA SEQRES 13 C 162 HIS GLN ARG MET GLY ASP SEQRES 1 D 104 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 D 104 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 D 104 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 D 104 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 D 104 ASP GLY LYS THR LEU GLY GLU CYS GLY PHE THR SER GLN SEQRES 6 D 104 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 D 104 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CYS ILE GLU SEQRES 8 D 104 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 1 E 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 E 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 E 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 E 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 E 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 E 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 E 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 E 97 ALA ASN PHE LEU ASP CYS SEQRES 1 F 162 GLY SER MET GLU ALA GLY ARG PRO ARG PRO VAL LEU ARG SEQRES 2 F 162 SER VAL ASN SER ARG GLU PRO SER GLN VAL ILE PHE CYS SEQRES 3 F 162 ASN ARG SER PRO ARG VAL VAL LEU PRO VAL TRP LEU ASN SEQRES 4 F 162 PHE ASP GLY GLU PRO GLN PRO TYR PRO THR LEU PRO PRO SEQRES 5 F 162 GLY THR GLY ARG ARG ILE HIS SER TYR ARG GLY HIS LEU SEQRES 6 F 162 TRP LEU PHE ARG ASP ALA GLY THR HIS ASP GLY LEU LEU SEQRES 7 F 162 VAL ASN GLN THR GLU LEU PHE VAL PRO SER LEU ASN VAL SEQRES 8 F 162 ASP GLY GLN PRO ILE PHE ALA ASN ILE THR LEU PRO VAL SEQRES 9 F 162 TYR THR LEU LYS GLU ARG CYS LEU GLN VAL VAL ARG SER SEQRES 10 F 162 LEU VAL LYS PRO GLU ASN TYR ARG ARG LEU ASP ILE VAL SEQRES 11 F 162 ARG SER LEU TYR GLU ASP LEU GLU ASP HIS PRO ASN VAL SEQRES 12 F 162 GLN LYS ASP LEU GLU ARG LEU THR GLN GLU ARG ILE ALA SEQRES 13 F 162 HIS GLN ARG MET GLY ASP SEQRES 1 G 121 SER MET LEU SER PRO ASN PRO PRO ASN LEU THR LYS LYS SEQRES 2 G 121 MET LYS LYS ILE VAL ASP ALA VAL ILE LYS TYR LYS ASP SEQRES 3 G 121 SER SER SER GLY ARG GLN LEU SER GLU VAL PHE ILE GLN SEQRES 4 G 121 LEU PRO SER ARG LYS GLU LEU PRO GLU TYR TYR GLU LEU SEQRES 5 G 121 ILE ARG LYS PRO VAL ASP PHE LYS LYS ILE LYS GLU ARG SEQRES 6 G 121 ILE ARG ASN HIS LYS TYR ARG SER LEU ASN ASP LEU GLU SEQRES 7 G 121 LYS ASP VAL MET LEU LEU CYS GLN ASN ALA GLN THR PHE SEQRES 8 G 121 ASN LEU GLU GLY SER LEU ILE TYR GLU ASP SER ILE VAL SEQRES 9 G 121 LEU GLN SER VAL PHE THR SER VAL ARG GLN LYS ILE GLU SEQRES 10 G 121 LYS GLU ASP ASP SEQRES 1 H 121 SER MET LEU SER PRO ASN PRO PRO ASN LEU THR LYS LYS SEQRES 2 H 121 MET LYS LYS ILE VAL ASP ALA VAL ILE LYS TYR LYS ASP SEQRES 3 H 121 SER SER SER GLY ARG GLN LEU SER GLU VAL PHE ILE GLN SEQRES 4 H 121 LEU PRO SER ARG LYS GLU LEU PRO GLU TYR TYR GLU LEU SEQRES 5 H 121 ILE ARG LYS PRO VAL ASP PHE LYS LYS ILE LYS GLU ARG SEQRES 6 H 121 ILE ARG ASN HIS LYS TYR ARG SER LEU ASN ASP LEU GLU SEQRES 7 H 121 LYS ASP VAL MET LEU LEU CYS GLN ASN ALA GLN THR PHE SEQRES 8 H 121 ASN LEU GLU GLY SER LEU ILE TYR GLU ASP SER ILE VAL SEQRES 9 H 121 LEU GLN SER VAL PHE THR SER VAL ARG GLN LYS ILE GLU SEQRES 10 H 121 LYS GLU ASP ASP HET PO4 B 201 5 HET PO4 C 301 5 HET PO4 C 302 5 HET PO4 C 303 5 HET GOL C 304 6 HET VLH C 305 77 HET CL E 201 1 HET PO4 F 301 5 HET PO4 F 302 5 HET VLH F 303 77 HET PO4 G1601 5 HETNAM PO4 PHOSPHATE ION HETNAM GOL GLYCEROL HETNAM VLH (2S,4R)-1-[(2R)-2-[3-[2-[4-[3-[4-[(1R,5S)-3-[3-AZANYL- HETNAM 2 VLH 6-(2-HYDROXYPHENYL)PYRIDAZIN-4-YL]-3,8- HETNAM 3 VLH DIAZABICYCLO[3.2.1]OCTAN-8-YL]PYRIDIN-2- HETNAM 4 VLH YL]OXYCYCLOBUTYL]OXYPIPERIDIN-1-YL]ETHOXY]-1,2-OXAZOL- HETNAM 5 VLH 5-YL]-3-METHYL-BUTANOYL]-N-[(1S)-1-[4-(4-METHYL-1,3- HETNAM 6 VLH THIAZOL-5-YL)PHENYL]ETHYL]-4-OXIDANYL-PYRROLIDINE-2- HETNAM 7 VLH CARBOXAMIDE HETNAM CL CHLORIDE ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 9 PO4 7(O4 P 3-) FORMUL 13 GOL C3 H8 O3 FORMUL 14 VLH 2(C57 H69 N11 O8 S) FORMUL 15 CL CL 1- FORMUL 20 HOH *57(H2 O) HELIX 1 AA1 THR A 23 LYS A 36 1 14 HELIX 2 AA2 PRO A 38 GLN A 42 5 5 HELIX 3 AA3 ARG B 33 LEU B 37 1 5 HELIX 4 AA4 SER B 39 LEU B 46 1 8 HELIX 5 AA5 PRO B 66 THR B 84 1 19 HELIX 6 AA6 ILE B 99 ASP B 111 1 13 HELIX 7 AA7 ASN C 141 GLN C 145 5 5 HELIX 8 AA8 THR C 157 VAL C 170 1 14 HELIX 9 AA9 LYS C 171 LEU C 178 5 8 HELIX 10 AB1 VAL C 181 ASP C 190 1 10 HELIX 11 AB2 ASN C 193 MET C 211 1 19 HELIX 12 AB3 THR D 23 LYS D 36 1 14 HELIX 13 AB4 PRO D 38 GLN D 42 5 5 HELIX 14 AB5 ARG E 33 LEU E 37 1 5 HELIX 15 AB6 SER E 39 LEU E 46 1 8 HELIX 16 AB7 PRO E 66 THR E 84 1 19 HELIX 17 AB8 ALA E 96 ASP E 111 1 16 HELIX 18 AB9 ASN F 141 GLN F 145 5 5 HELIX 19 AC1 THR F 157 VAL F 170 1 14 HELIX 20 AC2 LYS F 171 LEU F 178 5 8 HELIX 21 AC3 VAL F 181 ASP F 190 1 10 HELIX 22 AC4 ASN F 193 MET F 211 1 19 HELIX 23 AC5 LEU G 1458 TYR G 1472 1 15 HELIX 24 AC6 SER G 1482 ILE G 1486 5 5 HELIX 25 AC7 LEU G 1494 ILE G 1501 1 8 HELIX 26 AC8 ASP G 1506 ASN G 1516 1 11 HELIX 27 AC9 SER G 1521 ASN G 1540 1 20 HELIX 28 AD1 SER G 1544 LYS G 1566 1 23 HELIX 29 AD2 LEU H 1458 TYR H 1472 1 15 HELIX 30 AD3 SER H 1482 ILE H 1486 5 5 HELIX 31 AD4 LEU H 1494 ILE H 1501 1 8 HELIX 32 AD5 ASP H 1506 ASN H 1516 1 11 HELIX 33 AD6 SER H 1521 ASN H 1540 1 20 HELIX 34 AD7 SER H 1544 SER H 1559 1 16 SHEET 1 AA1 7 ARG A 43 TYR A 45 0 SHEET 2 AA1 7 ALA A 73 ALA A 78 -1 O GLY A 76 N TYR A 45 SHEET 3 AA1 7 ASP A 2 ARG A 9 1 N ARG A 8 O VAL A 75 SHEET 4 AA1 7 THR A 12 LYS A 19 -1 O ALA A 18 N VAL A 3 SHEET 5 AA1 7 GLU B 28 LYS B 32 1 O ILE B 30 N PHE A 15 SHEET 6 AA1 7 TYR B 18 ILE B 22 -1 N LEU B 21 O PHE B 29 SHEET 7 AA1 7 GLU B 59 ASN B 61 1 O VAL B 60 N ILE B 22 SHEET 1 AA2 2 ARG A 80 ALA A 81 0 SHEET 2 AA2 2 THR A 84 PHE A 85 -1 O THR A 84 N ALA A 81 SHEET 1 AA3 4 GLY C 106 TYR C 112 0 SHEET 2 AA3 4 PRO C 71 ASN C 78 -1 N PHE C 76 O ARG C 107 SHEET 3 AA3 4 ILE C 147 THR C 152 1 O ILE C 151 N CYS C 77 SHEET 4 AA3 4 LEU C 129 VAL C 130 -1 N LEU C 129 O THR C 152 SHEET 1 AA4 4 PRO C 95 PRO C 97 0 SHEET 2 AA4 4 VAL C 84 LEU C 89 -1 N TRP C 88 O GLN C 96 SHEET 3 AA4 4 LEU C 116 ASP C 121 -1 O ARG C 120 N LEU C 85 SHEET 4 AA4 4 LEU C 135 PHE C 136 -1 O PHE C 136 N TRP C 117 SHEET 1 AA5 7 ARG D 43 TYR D 45 0 SHEET 2 AA5 7 ALA D 73 ALA D 78 -1 O GLY D 76 N TYR D 45 SHEET 3 AA5 7 ASP D 2 ARG D 9 1 N ARG D 8 O VAL D 75 SHEET 4 AA5 7 THR D 12 LYS D 19 -1 O ALA D 18 N VAL D 3 SHEET 5 AA5 7 GLU E 28 LYS E 32 1 O ILE E 30 N PHE D 15 SHEET 6 AA5 7 TYR E 18 ILE E 22 -1 N LEU E 21 O PHE E 29 SHEET 7 AA5 7 GLU E 59 ASN E 61 1 O VAL E 60 N ILE E 22 SHEET 1 AA6 2 ARG D 80 ALA D 81 0 SHEET 2 AA6 2 THR D 84 PHE D 85 -1 O THR D 84 N ALA D 81 SHEET 1 AA7 4 GLY F 106 TYR F 112 0 SHEET 2 AA7 4 PRO F 71 ASN F 78 -1 N PHE F 76 O ARG F 107 SHEET 3 AA7 4 ILE F 147 THR F 152 1 O ILE F 151 N CYS F 77 SHEET 4 AA7 4 LEU F 129 VAL F 130 -1 N LEU F 129 O THR F 152 SHEET 1 AA8 4 PRO F 95 PRO F 97 0 SHEET 2 AA8 4 VAL F 84 LEU F 89 -1 N TRP F 88 O GLN F 96 SHEET 3 AA8 4 LEU F 116 ASP F 121 -1 O ARG F 120 N LEU F 85 SHEET 4 AA8 4 LEU F 135 PHE F 136 -1 O PHE F 136 N TRP F 117 CRYST1 167.680 88.044 84.978 90.00 105.89 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005964 0.000000 0.001698 0.00000 SCALE2 0.000000 0.011358 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012235 0.00000